Xiang Li
Affiliations
State University of New York
Technologies
Pharmaceutical Drug
Therapeutic
Indication
Personalized Medicine
Regenerative Medicine
Surgical Tool
We have developed and patented a novel preservation solution to be used as a clinical treatment for ischemia-reperfusion injury in organ transplantation, particularly intestinal transplantation
